Compound Summary
Compound Name: | 			Naloxone benzoylhydrazone | 
Compound CID: | 			9601084 | 
Synonyms: | 			Naloxone benzoylhydrazone Nalbzoh 119630-94-3 UNII-0W13ZI072Q 0W13ZI072Q More... | 
Iupac Name: | 			N-[(E)-[(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene]amino]benzamide | 
InChI: | 					InChI=1S/C26H27N3O4/c1-2-13-29-14-12-25-21-17-8-9-19(30)22(21)33-23(25)18(10-11-26(25,32)20(29)15-17)27-28-24(31)16-6-4-3-5-7-16/h2-9,20,23,30,32H,1,10-15H2,(H,28,31)/b27-18+/t20-,23+,25+,26-/m1/s1 | 
InChIKey: | 				AKXCFAYOTIEFOH-XTNAHFASSA-N | 
Canonical Smiles: | 		C=CCN1CCC23C4C(=NNC(=O)C5=CC=CC=C5)CCC2(C1CC6=C3C(=C(C=C6)O)O4)O | 
Isomeric Smiles: | 			C=CCN1CC[C@]23[C@@H]4/C(=N/NC(=O)C5=CC=CC=C5)/CC[C@]2([C@H]1CC6=C3C(=C(C=C6)O)O4)O | 
Molecular Weight: | 		445.5 | 
Molecular Formula: | 			C26H27N3O4 | 
Molecular Weight: | 		445.5 | 
Molecular Formula: | 			C26H27N3O4 | 
Hydrogen Bond Donor Count: | 			3 | 
Hydrogen Bond Acceptor Count: | 			6 | 
Rotatable Bond Count: | 			4 | 
Heavy Atom Count: | 					33 | 
Complexity: | 				841 | 
| Naloxone benzoylhydrazone | Naloxone benzoylhydrazone | 
|---|---|
Naloxone benzoylhydrazone | 			
Nalbzoh | 
119630-94-3 | 			
UNII-0W13ZI072Q | 
0W13ZI072Q | 			
N-(E)-(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro3,2-eisoquinolin-7-ylideneaminobenzamide | 
Benzoic acid, 2-(5alpha)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidenehydrazide | 			
6-Desoxy-6-benzoylhydrazido-N-allyl-14-hydroxydihydronormorphinone | 
Lopac0_000882 | 			
(5alpha)-4,5-Epoxy- | 
MLS000860072 | 			
Naloxone benzoylhydrazone, solid | 
CHEMBL1256836 | 			
SCHEMBL15423902 | 
HMS3412O16 | 			
HMS3676O16 | 
MFCD05662358 | 			
AKOS024456586 | 
CCG-204964 | 			
SDCCGSBI-0050857.P002 | 
NCGC00092281-01 | 			
NCGC00092281-02 | 
NCGC00092281-03 | 			
NCGC00092281-04 | 
Benzoic acid, ((5alpha)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene)hydrazide | 			
SMR000326930 | 
HY-107743 | 			
CS-0029440 | 
EU-0100882 | 			
N-165 | 
SR-01000075513 | 			
SR-01000075513-1 | 
3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidenehydrazide benzoic acid | 			
(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidenehydrazide benzoic acid | 
2-(5a)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidenehydrazide benzoic acid | 			
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 8 | NS | N2 | 24134630 | Inactive | 
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 8 | 1 | 1 |